Suppr超能文献

基于呋喃的含5-苯基硝基查尔酮作为新型强效单胺氧化酶B抑制剂的开发。

Development of 5-phenylnitro bearing furan-based chalcones as a new class of potent MAO-B inhibitors.

作者信息

Kalathil Kadeeja Thottungal, Pandey Bishnu Prasad, Peedikayil Arshida Thottile, Abdu Raihan Arikkattel, Sreekumari Rajasree Raghavan, Alfagham Alanoud T, Elgorban Abdallah M, Kumar Sunil, Kim Hoon, Dev Sanal, Mathew Bijo

机构信息

Centre for Experimental Drug Design and Development, Department of Pharmaceutical Chemistry, Al-Shifa College of Pharmacy, Affiliated to Kerala University of Health Sciences, Perinthalmanna, India.

Department of Pharmacy, College of Pharmacy, Sunchon National University, Suncheon, Republic of Korea.

出版信息

Future Med Chem. 2025 Apr;17(7):779-787. doi: 10.1080/17568919.2025.2485671. Epub 2025 Apr 3.

Abstract

AIM

The purpose is to synthesize a new class of furan-based chalcone compounds (KD1-KD14) and to investigate their monoamine oxidase (MAO)-A and -B inhibitory activities.

MATERIAL AND METHOD

The 14 chalcones were synthesized using an open mortar and pestle. Lead molecules were screened via inhibitory activity, BBB permeability, and computation studies.

RESULTS

Most of the tested compounds showed promising activity for MAO-B over than MAO-A. Among the molecules, KD1 and KD9 revealed the significant inhibitory potentials toward MAO-B with IC values of 0.023 ± 0.004 and 0.015 ± 0.001 µM, respectively, and with high selectivity indices of 723.04 and >2666.66, respectively, over MAO-A. Further, kinetics and reversibility test revealed that both KD1 and KD9 were competitive reversible MAO-B inhibitors with K values of 13.5 ± 4.95 and 6.15 ± 0.92 nM, respectively. Additionally, the PAMPA test showed that both KD1 and KD9 compounds permeated the central nervous system. Furthermore, molecular docking and dynamics simulations showed that both the chemicals formed pi-cation and hydrogen bonds with the MAO-B pocket and stabilized the MAO-B over the course of a 100 ns simulation.

CONCLUSION

Our results revealed that KD1 and KD9 are potent selective, reversible, and competitive MAO-B inhibitors.

摘要

目的

合成一类新型的基于呋喃的查尔酮化合物(KD1-KD14),并研究它们对单胺氧化酶(MAO)-A和-B的抑制活性。

材料与方法

使用开放式研钵和杵合成了14种查尔酮。通过抑制活性、血脑屏障通透性和计算研究筛选先导分子。

结果

大多数测试化合物对MAO-B的活性优于MAO-A。在这些分子中,KD1和KD9对MAO-B显示出显著的抑制潜力,IC值分别为0.023±0.004和0.015±0.001μM,对MAO-A的选择性指数分别为723.04和>2666.66。此外,动力学和可逆性测试表明,KD1和KD9都是竞争性可逆MAO-B抑制剂,K值分别为13.5±4.95和6.15±0.92 nM。此外,PAMPA测试表明,KD1和KD9化合物均可透过中枢神经系统。此外,分子对接和动力学模拟表明,这两种化合物均与MAO-B口袋形成π-阳离子和氢键,并在100 ns模拟过程中使MAO-B稳定。

结论

我们的结果表明,KD1和KD9是有效的选择性、可逆性和竞争性MAO-B抑制剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验